Gene Therapy Surges as Investment and M&A Frenzy Accelerates, Fueled by Landmark Clinical Triumphs
The gene therapy landscape is undergoing a seismic transformation, evolving from a realm of high-risk, experimental science into one of the most dynamic and fiercely competitive investment arenas in global Continue Reading